FDA inspection
Halo Pharmaceutical Canada Inc: FDA inspection ending Jul 12, 2019
FDA inspection 1100346 · No Action Indicated (NAI) · Mirabel
Key facts
| Inspection ID | 1100346 |
|---|---|
| Firm | Halo Pharmaceutical Canada Inc |
| FEI number | 3009856628 |
| Address | 17800 Lapointe St |
| City | Mirabel |
| Fiscal year | 2019 |
| Inspection end date | Jul 12, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data